fluorescein-5-isothiocyanate has been researched along with fentanyl in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Blagus, T; Cemazar, M; Kosjek, T; Markelc, B; Miklavcic, D; Preat, V; Sersa, G | 1 |
Ding, W; Lao, Y; Li, X; Mo, Y; Wang, B; Zhang, X; Zheng, Y | 1 |
2 other study(ies) available for fluorescein-5-isothiocyanate and fentanyl
Article | Year |
---|---|
In vivo real-time monitoring system of electroporation mediated control of transdermal and topical drug delivery.
Topics: Adjuvants, Anesthesia; Administration, Cutaneous; Animals; Antibiotics, Antineoplastic; Dextrans; Doxorubicin; Drug Delivery Systems; Electroporation; Female; Fentanyl; Fluorescein-5-isothiocyanate; Mice; Mice, Inbred BALB C; Skin; Skin Absorption | 2013 |
Fentanyl alleviates intestinal mucosal barrier damage in rats with severe acute pancreatitis by inhibiting the MMP-9/FasL/Fas pathway.
Topics: Acute Disease; Amine Oxidase (Copper-Containing); Amylases; Animals; Caco-2 Cells; Dextrans; Eosine Yellowish-(YS); Fas Ligand Protein; Fentanyl; Fluorescein-5-isothiocyanate; Hematoxylin; Humans; Intestinal Mucosa; Lipase; Lipopolysaccharides; Matrix Metalloproteinase 9; Occludin; Pancreatitis; Rats | 2022 |